Greenland Capital Management »

Bicara Therapeutics shares owned by Greenland Capital Management

Quarter-by-quarter ownership of Bicara Therapeutics shares owned by Greenland Capital Management from 13F filings

Historical chart of Greenland Capital Management investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Greenland Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Greenland Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $313k 12k 25.47

More positions owned by Greenland Capital Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Ishares Tr U.s. Real Es Etf Call Option (IYR)
Hess (HES)
PPL Corporation (PPL)
Select Sector Spdr Tr Indl (XLI)
Alliant Energy Corporation (LNT)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Vaneck Etf Trust Semiconductr Etf (SMH)
Amazon (AMZN)
Consolidated Edison (ED)
Booking Holdings (BKNG)
MercadoLibre (MELI)

View all positions for Greenland Capital Management

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Tpg Gp A
Deerfield Management Company
Braidwell
T. Rowe Price Associates
Fairmount Funds Management
Baker Bros. Advisors
Blackstone Group
First Turn Management
Vestal Point Capital
Point72 Asset Management
Woodline Partners
OrbiMed Advisors
Citadel Advisors

View all funds holding Bicara Therapeutics